Spots Global Cancer Trial Database for ring sideroblasts
Every month we try and update this database with for ring sideroblasts cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes | NCT02631070 | Myelodysplastic... | Luspatercept Placebo | 18 Years - | Celgene | |
A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes | NCT02631070 | Myelodysplastic... | Luspatercept Placebo | 18 Years - | Celgene | |
Biocollection in MyeloDysplastic Syndrome (P-MDS) | NCT04869683 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Myelodysplastic... Acute Myeloid L... Chromosome Abno... | description of ... | 18 Years - | University Hospital, Brest | |
A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes | NCT02631070 | Myelodysplastic... | Luspatercept Placebo | 18 Years - | Celgene |